Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UPADACITINIB vs VADADUSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UPADACITINIB vs VADADUSTAT: Safety Overview

Metric UPADACITINIB VADADUSTAT
Total FAERS Reports 65,656 175
Deaths Reported 2,406 83
Death Rate 3.7% 47.4%
Hospitalizations 15,931 54
Average Patient Age 57.4 yrs 76.3 yrs
% Female Patients 71.2% 40.2%
FDA Approval Date Apr 26, 2024 Mar 27, 2024
Manufacturer AbbVie Inc. Akebia Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription